Back to Results
First PageMeta Content
Technology / Humanitarian Device Exemption / Medical device / Investigational Device Exemption / Federal Food /  Drug /  and Cosmetic Act / Premarket approval / Title 21 of the Code of Federal Regulations / Center for Biologics Evaluation and Research / Medicine / Food and Drug Administration / Health


Draft Guidance for HDE Holders, Institutional Review Boards (IRBs), Clinical Investigators, and FDA Staff
Add to Reading List

Open Document

File Size: 112,91 KB

Share Result on Facebook

City

Rockville / Spring / /

Country

United States / /

/

Facility

CBER Document Control Center / Rockville Pike / /

/

IndustryTerm

manufacturing defect / manufacturing / /

MedicalCondition

disease / rare disease / /

Organization

CBER Document Control Center / U.S. Department of Health and Human Services / office of Communication / Outreach and Development / Institutional Review Board / Food and Drug Administration / Center for Devices and Radiological Health / Division of Dockets Management / Food and Drug Administration Center for Devices / Radiological Health / Device Evaluation Program Operations Staff Center for Biological Evaluation and Research Contains Nonbinding Recommendations / FDA’s HUD / FDA’s office of Orphan Products Development / Radiological Heath Document Mail Center / office of Orphan Products Development / Radiological Health office of Device Evaluation Program Operations / Center for Biologics Evaluation and Research / Center for Biologics Evaluation and Research Food and Drug Administration / /

Person

Sheila Brown / /

/

Position

Governor / clinical investigator / /

ProvinceOrState

Maryland / /

PublishedMedium

Public Law / /

URL

http /

SocialTag